Caprock Group LLC Buys Shares of 39,997 Corteva, Inc. $CTVA

Caprock Group LLC purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 39,997 shares of the company’s stock, valued at approximately $2,967,000.

Several other hedge funds have also recently made changes to their positions in the stock. Krilogy Financial LLC purchased a new stake in Corteva in the third quarter worth approximately $588,000. Advisors Asset Management Inc. lifted its holdings in shares of Corteva by 6.6% during the 3rd quarter. Advisors Asset Management Inc. now owns 46,507 shares of the company’s stock valued at $3,145,000 after buying an additional 2,883 shares during the period. Center for Financial Planning Inc. boosted its stake in shares of Corteva by 52.3% in the 3rd quarter. Center for Financial Planning Inc. now owns 1,284 shares of the company’s stock worth $87,000 after buying an additional 441 shares during the last quarter. Stratos Wealth Partners LTD. grew its holdings in shares of Corteva by 1.5% in the third quarter. Stratos Wealth Partners LTD. now owns 63,248 shares of the company’s stock worth $4,278,000 after acquiring an additional 960 shares during the period. Finally, MQS Management LLC increased its position in Corteva by 17.1% during the third quarter. MQS Management LLC now owns 11,577 shares of the company’s stock valued at $783,000 after acquiring an additional 1,694 shares during the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Down 1.8%

CTVA opened at $73.99 on Friday. The stock has a market cap of $50.00 billion, a price-to-earnings ratio of 46.83, a price-to-earnings-growth ratio of 2.57 and a beta of 0.75. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The firm’s fifty day moving average is $69.49 and its 200 day moving average is $68.45. Corteva, Inc. has a fifty-two week low of $53.40 and a fifty-two week high of $77.41.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. During the same quarter in the prior year, the business posted $0.32 EPS. Corteva’s revenue for the quarter was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is 45.57%.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on CTVA shares. BNP Paribas Exane raised their target price on Corteva from $70.00 to $72.00 and gave the stock a “neutral” rating in a research report on Monday, November 17th. Wolfe Research raised their price objective on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Mizuho boosted their target price on shares of Corteva from $78.00 to $80.00 and gave the company an “outperform” rating in a research report on Friday, January 16th. UBS Group downgraded shares of Corteva from a “buy” rating to a “hold” rating in a research report on Monday. Finally, Citigroup lifted their price target on shares of Corteva from $74.00 to $80.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $82.20.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.